Irny 1000mg Injection contains Ferric Carboxymaltose 1000mg, an intravenous iron preparation indicated for the treatment of iron deficiency anemia when oral iron therapy is ineffective or cannot be used. Ferric Carboxymaltose provides a stable complex that allows controlled release of iron, facilitating rapid replenishment of iron stores and hemoglobin synthesis. This formulation is particularly beneficial in patients with chronic kidney disease, inflammatory bowel disease, postpartum anemia, or those undergoing chemotherapy, where iron deficiency is prevalent. Administration is typically performed as a single or multiple intravenous infusions, depending on the patient’s iron deficit and clinical condition. Irny 1000mg Injection offers the advantage of delivering a high dose of iron in a single session, reducing the frequency of hospital visits and improving patient compliance. Common adverse effects may include transient hypophosphatemia, injection site reactions, nausea, dizziness, or headache; however, serious hypersensitivity reactions are rare but require immediate medical attention. Prior to administration, assessment of iron status, including serum ferritin and transferrin saturation, is recommended to avoid iron overload. Irny 1000mg Injection should be used under strict medical supervision with appropriate monitoring to ensure efficacy and safety in the management of iron deficiency anemia.